Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383K Sell
1,057
-663
-39% -$227K 0.04% 209
2026
Q1
$605K Buy
1,720
+570
+50% +$203K 0.07% 147
2025
Q4
$377K Sell
1,150
-494
-30% -$157K 0.05% 185
2025
Q3
$464K Buy
1,644
+639
+64% +$185K 0.07% 138
2025
Q2
$281K Sell
1,005
-260
-21% -$73.7K 0.05% 189
2025
Q1
$394K Buy
1,265
+237
+23% +$70K 0.07% 161
2024
Q4
$268K Sell
1,028
-102
-9% -$30.3K 0.06% 156
2024
Q3
$364K Buy
1,130
+220
+24% +$72K 0.1% 118
2024
Q2
$284K Hold
910
0.08% 148
2024
Q1
$259K Sell
910
-5
-0.5% -$1.46K 0.07% 161
2023
Q4
$264K Buy
915
+5
+0.5% +$1.36K 0.07% 148
2023
Q3
$245K Hold
910
0.08% 169
2023
Q2
$202K Hold
910
0.06% 197
2023
Q1
$220K Hold
910
0.06% 177
2022
Q4
$239K Hold
910
0.08% 155
2022
Q3
$205K Sell
910
-141
-13% -$34.2K 0.07% 170
2022
Q2
$255K Buy
1,051
+136
+15% +$33.3K 0.08% 162
2022
Q1
$221K Sell
915
-1,068
-54% -$245K 0.06% 181
2021
Q4
$446K Sell
1,983
-206
-9% -$43.5K 0.08% 166
2021
Q3
$465K Buy
2,189
+1,090
+99% +$251K 0.09% 160
2021
Q2
$267K Sell
1,099
-108
-9% -$26.6K 0.06% 192
2021
Q1
$300K Buy
1,207
+200
+20% +$47.7K 0.07% 165
2020
Q4
$231K Buy
1,007
+160
+19% +$36.9K 0.06% 175
2020
Q3
$215K Buy
+847
New +$210K 0.06% 167
2020
Q1
Sell
-888
Closed -$214K 125
2019
Q4
$214K Buy
+888
New +$196K 0.06% 105

Other funds holding AMGN

True North Advisors's AMGN Position: Q2 2026 in Review

True North Advisors reduced its Amgen (AMGN) stake by 39% in Q2 2026, selling an estimated $227K and leaving 1,057 shares worth $383K. The position accounts for 0.04% of the portfolio, ranked #209.

True North Advisors first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $605K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • True North Advisors held 1,057 shares of Amgen worth $383K as of Q2 2026.
  • True North Advisors sold 663 Amgen shares in Q2 2026, an estimated $227K.
  • Amgen made up 0.04% of True North Advisors's portfolio in Q2 2026, its #209 holding.
  • True North Advisors first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
  • True North Advisors's Amgen position peaked at $605K in Q1 2026.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.